ALIREPOTINIB – Repotrectinib

Repotrectinib is listed in the VetinoPharma B2B pharmaceutical product catalog under Oncology. It is commonly referenced in treatment areas related to ros1-positive non-small cell lung cancer or ntrk fusion-positive solid tumor reference and should be reviewed for the relevant market, documentation, and intended business context. For wholesale, distribution, or sourcing inquiries, please contact the VetinoPharma team.